Clinical Study to Evaluate the Efficacy of Prasterone Treatment for Atrophy Vulvovaginal in Postmenopausal Women With Vulvar / Vestibular Pain
NCT04898556
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Vulvovaginal Atrophy
Interventions
DRUG:
Prasterone 6.5 MG
OTHER:
Placebo
Sponsor
Dr. Santiago Palacios